Steven Ferguson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Steven Ferguson has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Anne Marie Healy
EPSRC-SFI Centre for Doctoral Training in Transformative Pharmaceutical Technologies, Ireland; SSPC, The Research Ireland Centre for Pharmaceuticals, School of Pharmacy and Pharmaceutical Sciences, Panoz Institute, Trinity College Dublin, Dublin 2, Ireland
5 shared publications - Denis P. Dowling
I-Form Advanced Manufacturing Research Centre, School of Mechanical and Materials Engineering, University College Dublin, Dublin, Ireland
3 shared publications Geoff Gibson
Pfizer Ireland Pharmaceuticals, Ringaskiddy, Ireland
3 shared publications- Joanna Francelle McGouran
RINN Pharma and Biopharma Centre School of Chemistry and Trinity Biomedical Sciences Institute Trinity College Dublin The University of Dublin Dublin Ireland
3 shared publications - Kevin P. Girard
Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States
3 shared publications Rafael Lopez-Rodriguez
School of Chemical and Bioprocess Engineering, University College Dublin, Belfield, Dublin 4, Ireland
3 shared publications
Latest Publications
- Open Access
- 17 July 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (39) , e8835235
Glutathione‐Responsive Acyl‐Modifications for Targeted RNA Decaging and Prolonged Protein Synthesis
A series of disulfide‐based, self‐immolative acyl conjugates have been designed and tested for reversibly protecting the ribose 2’‐hydroxy position of RNA. These modifications were found to be responsive to endogenous glutathione levels for efficient RNA recovery both in solution and cultured cells. Through this modification strategy, we achieve shielding of the biomolecule from both nuclease enzymes and translational machinery, allowing for a tunable release of RNA with improved cellular stability and minimal innate immune activation. The self‐immolative RNA deprotection includes a cyclization step which exhibits differing kinetic profiles based on ring size and electronic properties. Moreover, we demonstrate sustained target protein production for both green‐fluorescent protein and nanoluciferase in cell models. Both acylated mRNA models resulted in significant increases in protein expression compared to the unmodified mRNA control, with increases in protein expression of up to 600% and sustained higher protein expression of modified mRNA samples observed over 120 h in comparison to unmodified RNA. These exciting results highlight the versatility of our approach in the design of next‐generation RNA‐based prodrugs.
- 17 July 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (39) , e8835235
Open AccessGlutathione‐Responsive Acyl‐Modifications for Targeted RNA Decaging and Prolonged Protein Synthesis
A series of disulfide‐based, self‐immolative acyl conjugates have been designed and tested for reversibly protecting the ribose 2’‐hydroxy position of RNA. These modifications were found to be responsive to endogenous glutathione levels for efficient RNA recovery both in solution and cultured cells. Through this modification strategy, we achieve shielding of the biomolecule from both nuclease enzymes and translational machinery, allowing for a tunable release of RNA with improved cellular stability and minimal innate immune activation. The self‐immolative RNA deprotection includes a cyclization step which exhibits differing kinetic profiles based on ring size and electronic properties. Moreover, we demonstrate sustained target protein production for both green‐fluorescent protein and nanoluciferase in cell models. Both acylated mRNA models resulted in significant increases in protein expression compared to the unmodified mRNA control, with increases in protein expression of up to 600% and sustained higher protein expression of modified mRNA samples observed over 120 h in comparison to unmodified RNA. These exciting results highlight the versatility of our approach in the design of next‐generation RNA‐based prodrugs.
- Open Access
- 17 July 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (39) , e8835235
Glutathione‐Responsive Acyl‐Modifications for Targeted RNA Decaging and Prolonged Protein Synthesis
A series of disulfide‐based, self‐immolative acyl conjugates have been designed and tested for reversibly protecting the ribose 2’‐hydroxy position of RNA. These modifications were found to be responsive to endogenous glutathione levels for efficient RNA recovery both in solution and cultured cells. Through this modification strategy, we achieve shielding of the biomolecule from both nuclease enzymes and translational machinery, allowing for a tunable release of RNA with improved cellular stability and minimal innate immune activation. The self‐immolative RNA deprotection includes a cyclization step which exhibits differing kinetic profiles based on ring size and electronic properties. Moreover, we demonstrate sustained target protein production for both green‐fluorescent protein and nanoluciferase in cell models. Both acylated mRNA models resulted in significant increases in protein expression compared to the unmodified mRNA control, with increases in protein expression of up to 600% and sustained higher protein expression of modified mRNA samples observed over 120 h in comparison to unmodified RNA. These exciting results highlight the versatility of our approach in the design of next‐generation RNA‐based prodrugs.
- 17 July 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (39) , e8835235
Open AccessGlutathione‐Responsive Acyl‐Modifications for Targeted RNA Decaging and Prolonged Protein Synthesis
A series of disulfide‐based, self‐immolative acyl conjugates have been designed and tested for reversibly protecting the ribose 2’‐hydroxy position of RNA. These modifications were found to be responsive to endogenous glutathione levels for efficient RNA recovery both in solution and cultured cells. Through this modification strategy, we achieve shielding of the biomolecule from both nuclease enzymes and translational machinery, allowing for a tunable release of RNA with improved cellular stability and minimal innate immune activation. The self‐immolative RNA deprotection includes a cyclization step which exhibits differing kinetic profiles based on ring size and electronic properties. Moreover, we demonstrate sustained target protein production for both green‐fluorescent protein and nanoluciferase in cell models. Both acylated mRNA models resulted in significant increases in protein expression compared to the unmodified mRNA control, with increases in protein expression of up to 600% and sustained higher protein expression of modified mRNA samples observed over 120 h in comparison to unmodified RNA. These exciting results highlight the versatility of our approach in the design of next‐generation RNA‐based prodrugs.
- 23 November 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 687, 126428
Isolation-free manufacturing of lipophilic API-ionic liquids (API-ILs) and their solidified products for oral solid dosage formulations
- 23 November 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 687, 126428
Isolation-free manufacturing of lipophilic API-ionic liquids (API-ILs) and their solidified products for oral solid dosage formulations
- Open Access
- 19 May 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (6) , 3061-3072
Comparative Analysis of mRNA Degradation Kinetics Using Chromatographic and Electrophoretic Methods
The effects of temperature and lipid nanoparticle (LNP) encapsulation on mRNA chemical stability were assessed for two model mRNA (EGFP mRNA, 996 nt; Fluc mRNA, 1929 nt) using capillary electrophoresis (CE) and ion pair reversed phase high performance liquid chromatography (IP-RP-HPLC) to measure mRNA integrity. The apparent degradation rates for unencapsulated ("naked") mRNA were method-dependent for Fluc mRNA, with rates up to 50% greater when measured using CE compared to IP-RP-HPLC. This discrepancy is attributed to differences in mass resolution, separation mechanisms and/or linearity of the two methods and was not observed for EGFP mRNA. The apparent reaction order for naked mRNA degradation varied with storage temperature, being zero-order at 35 °C and first-order at 50 °C. Encapsulation of mRNA using LNPs slowed mRNA degradation by up to 9-fold relative to naked mRNA controls stored under the same conditions. Encapsulation also induced changes in thermal unfolding patterns. Overall, the results show the benefits and limitations of each analytical method for determining mRNA degradation kinetics and the effects of temperature and LNP encapsulation on mRNA stability.
- 19 May 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (6) , 3061-3072
Open AccessComparative Analysis of mRNA Degradation Kinetics Using Chromatographic and Electrophoretic Methods
The effects of temperature and lipid nanoparticle (LNP) encapsulation on mRNA chemical stability were assessed for two model mRNA (EGFP mRNA, 996 nt; Fluc mRNA, 1929 nt) using capillary electrophoresis (CE) and ion pair reversed phase high performance liquid chromatography (IP-RP-HPLC) to measure mRNA integrity. The apparent degradation rates for unencapsulated ("naked") mRNA were method-dependent for Fluc mRNA, with rates up to 50% greater when measured using CE compared to IP-RP-HPLC. This discrepancy is attributed to differences in mass resolution, separation mechanisms and/or linearity of the two methods and was not observed for EGFP mRNA. The apparent reaction order for naked mRNA degradation varied with storage temperature, being zero-order at 35 °C and first-order at 50 °C. Encapsulation of mRNA using LNPs slowed mRNA degradation by up to 9-fold relative to naked mRNA controls stored under the same conditions. Encapsulation also induced changes in thermal unfolding patterns. Overall, the results show the benefits and limitations of each analytical method for determining mRNA degradation kinetics and the effects of temperature and LNP encapsulation on mRNA stability.
- Open Access
- 13 May 2025
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (6) , 1577-1592
Scalable Membrane Enabled One-Pot Liquid-Phase Oligonucleotide Synthesis
In this article, a new one-pot liquid-phase oligonucleotide synthesis (OP-LPOS) route enabled by organic solvent resistant (OSR) ceramic membranes is described. This approach was demonstrated through the synthesis of 6mer and 18mer 2’-OMe phosphorothioate oligonucleotides with high stepwise filtration yields (97–100%), and high crude purity (∼72% for 18mer) using just 1.5 equiv of phosphoramidites. Ceramic organic solvent nanofiltration (OSN) and ultrafiltration (OSU) membranes were used to selectively retain the growing oligonucleotide, which is reversibly tethered to a 4-arm branched PEG support, facilitating lower molecular weight reaction byproducts to permeate to waste. This is the first application of ceramic ultrafiltration membranes in such an application, which enables purification of intermediate products in just 5 diavolumes with high permeance (13 Lm–2 h–1 bar–1). We employ a one-pot approach that integrates sequential coupling, sulfurization, and detritylation steps, followed by a single membrane purification step per chain extension cycle. Analysis of the methodology indicates that the homogeneous reactions and separation performance, which use commercially available reagents and highly scalable membrane systems, represent a promising alternative to solid-phase oligonucleotide synthesis (SPOS) for large-scale manufacturing of therapeutic oligonucleotides. Furthermore, the combination of OP-LPOS with membrane separation increases intermediate product purity and yield. It reduces the number of unit operations, cycle times, and process mass intensity (PMI) compared to the previous state-of-the-art membrane-based LPOS.
- 13 May 2025
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (6) , 1577-1592
Open AccessScalable Membrane Enabled One-Pot Liquid-Phase Oligonucleotide Synthesis
In this article, a new one-pot liquid-phase oligonucleotide synthesis (OP-LPOS) route enabled by organic solvent resistant (OSR) ceramic membranes is described. This approach was demonstrated through the synthesis of 6mer and 18mer 2’-OMe phosphorothioate oligonucleotides with high stepwise filtration yields (97–100%), and high crude purity (∼72% for 18mer) using just 1.5 equiv of phosphoramidites. Ceramic organic solvent nanofiltration (OSN) and ultrafiltration (OSU) membranes were used to selectively retain the growing oligonucleotide, which is reversibly tethered to a 4-arm branched PEG support, facilitating lower molecular weight reaction byproducts to permeate to waste. This is the first application of ceramic ultrafiltration membranes in such an application, which enables purification of intermediate products in just 5 diavolumes with high permeance (13 Lm–2 h–1 bar–1). We employ a one-pot approach that integrates sequential coupling, sulfurization, and detritylation steps, followed by a single membrane purification step per chain extension cycle. Analysis of the methodology indicates that the homogeneous reactions and separation performance, which use commercially available reagents and highly scalable membrane systems, represent a promising alternative to solid-phase oligonucleotide synthesis (SPOS) for large-scale manufacturing of therapeutic oligonucleotides. Furthermore, the combination of OP-LPOS with membrane separation increases intermediate product purity and yield. It reduces the number of unit operations, cycle times, and process mass intensity (PMI) compared to the previous state-of-the-art membrane-based LPOS.
- Open Access
- 2 May 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 678, 125649
Solidified ionic liquid-based formulations of metformin with enhanced GI epithelial permeability
- 2 May 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 678, 125649
Open AccessSolidified ionic liquid-based formulations of metformin with enhanced GI epithelial permeability
- 2 November 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 667, 124878
Development of polymer-encapsulated microparticles of a lipophilic API-IL and its lipid based formulations for enhanced solubilisation
- 2 November 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 667, 124878
Development of polymer-encapsulated microparticles of a lipophilic API-IL and its lipid based formulations for enhanced solubilisation
- Open Access
- 17 October 2024
- Published by Royal Society of Chemistry (RSC) in Reaction Chemistry & Engineering
- Vol. 10 (1) , 251-266
Development and simulation of annular flow photoreactors: integration of light-diffusing fibers as optical diffusers with laser diodes
Laser driven platform for photochemical reactions. Modelling: predictability and optimization.
- 17 October 2024
- Published by Royal Society of Chemistry (RSC) in Reaction Chemistry & Engineering
- Vol. 10 (1) , 251-266
Open AccessDevelopment and simulation of annular flow photoreactors: integration of light-diffusing fibers as optical diffusers with laser diodes
Laser driven platform for photochemical reactions. Modelling: predictability and optimization.
- Open Access
- 5 September 2024
- Published by Wiley in ChemBioChem
- Vol. 25 (21) , e202400528
Zinc‐Binding Oligonucleotide Backbone Modifications for Targeting a DNA‐Processing Metalloenzyme
A series of chemically‐modified oligonucleotides for targeting the DNA repair nuclease SNM1A have been designed and synthesised. Each oligonucleotide contains a modified internucleotide linkage designed to both mimic the native phosphodiester backbone and chelate to the catalytic zinc ion(s) in the SNM1A active site. Dinucleoside phosphoramidites containing urea, squaramide, sulfanylacetamide, and sulfinylacetamide linkages were prepared and employed successfully in solid‐phase oligonucleotide synthesis. All the modified oligonucleotides were found to interact with SNM1A in a gel electrophoresis‐based assay, demonstrating the first examples of inhibition of DNA damage repair enzymes for many of these groups in oligonucleotides. One strand containing a sulfinylacetamide‐linkage was found to have the strongest interaction with SNM1A and was further tested in a real‐time fluorescence assay. This allowed an IC50 value of 231 nM to be determined, significantly lower than previously reported substrate‐mimics targeting this enzyme. It is expected that these modified oligonucleotides will serve as a scaffold for the future development of fluorescent or biotin‐labelled probes for the in vivo study of DNA repair processes.
- 5 September 2024
- Published by Wiley in ChemBioChem
- Vol. 25 (21) , e202400528
Open AccessZinc‐Binding Oligonucleotide Backbone Modifications for Targeting a DNA‐Processing Metalloenzyme
A series of chemically‐modified oligonucleotides for targeting the DNA repair nuclease SNM1A have been designed and synthesised. Each oligonucleotide contains a modified internucleotide linkage designed to both mimic the native phosphodiester backbone and chelate to the catalytic zinc ion(s) in the SNM1A active site. Dinucleoside phosphoramidites containing urea, squaramide, sulfanylacetamide, and sulfinylacetamide linkages were prepared and employed successfully in solid‐phase oligonucleotide synthesis. All the modified oligonucleotides were found to interact with SNM1A in a gel electrophoresis‐based assay, demonstrating the first examples of inhibition of DNA damage repair enzymes for many of these groups in oligonucleotides. One strand containing a sulfinylacetamide‐linkage was found to have the strongest interaction with SNM1A and was further tested in a real‐time fluorescence assay. This allowed an IC50 value of 231 nM to be determined, significantly lower than previously reported substrate‐mimics targeting this enzyme. It is expected that these modified oligonucleotides will serve as a scaffold for the future development of fluorescent or biotin‐labelled probes for the in vivo study of DNA repair processes.
- 9 February 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (6) , 2203-2212
Development of an Early Phase Process for a Potent Oligodendrocyte Precursor Cell Differentiator
- 9 February 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (6) , 2203-2212
Development of an Early Phase Process for a Potent Oligodendrocyte Precursor Cell Differentiator